Nicola studied Biology at the University of Constance (DE) and obtained her PhD in 2011 at the University of Zurich (CH). Her PhD studies were part of a cooperative initiative between the Cardiovascular Research Group and the Institute of Physiology (UZH, CH), allowing her to investigate mechanisms of obesity-induced endothelial dysfunction from different angles. After her PhD, Nicola joined the Hematology Medical Affairs Department of the pharmaceutical company Celgene GmbH (CH). In that time, she obtained a profound expertise in medical writing, coordination of clinical trials as well as development of scientific strategies. Given her expertise in in coordination and medical writing, she worked as a postdoctoral researcher from 2021 to 2022 in the Gebhard Lab, thereby focusing on data analysis and presentation but also manuscript and grant proposal writing.

Pubmed